The newest drug for congestive heart failure, Entresto, a fixed combination of valsartan and sacubitril, has just hit the market at an eleva...
Read More
07.54
Add Comment
CHF,
clinical trials,
Entresto,
evidence-based medicine,
manipulating clinical research,
Novartis,
sacubitril
Edit